Una sitografia in costruzione
M. Facchini, I brevetti dei vaccini anti Covid-19 e i profitti sulla pandemia, in Altraeconomia, 26 gennaio 2021
Vaccini Covid e ritardi, il nodo dei brevetti, Fortune, 25 gennaio 2021
Vaccini Covid, Silvio Garattini: “Accelerare la fase 3 di quello italiano. O avere il coraggio di abolire i brevetti e produrli direttamente”, in Il Fatto Quotidiano 25 gennaio 2021
Vaccini Covid in ritardo (intervista a S. Garattini), Il Mattino, 25 gennaio 2021
F. De Benedetti, Vaccini, indagine europea per mancata trasparenza della Commissione sui contratti, Domani, 22 gennaio 2021
D.M. De Luca, Anche in Europa ora si pensa di sospendere i brevetti sui vaccini, Domani, 22 gennaio 2021
WHO platform for pharmaceutical firms unused since pandemic began, The Guardian, 22.01.2021
G. Strada, Vaccino anti-covid, Gino Strada: “Decidono i Governi o i consigli di amministrazione di queste multinazionali?“, La7, Piazza pulita, 21 gennaio 2021
R. Petrella, Vaccini, la salute per tutti sotto il dominio del mercato, Il Manifesto, 21 gennaio 2021
Vaccino Covid. Scaccabarozzi (Farmindustria): “Liberare brevetti non è la soluzione”, in Quotidiano Sanità, 21 gennaio 2021
M. Sopelsa, Ecco il vaccino, ma a che prezzo?, Il Bo Live, 27 dicembre 2020
Papa Francesco, Messaggio Urbi et Orbi del Santo Padre Francesco, 25 dicembre 2020
A. Andrieansjah, The Impact of COVID-19 on Intellectual Property Legal System Related to Public Health in Connection with TRPS Flexibilities in Indonesia, Vol. 13 No. 2 (2020): Indonesian Law Journal Volume 13 No. 2, 2020
H. Miller, S. Decker, Vaccinating Billions Means Finding Ways Around a Patent Impasse, Bloomberg, 16 Dec. 2020
Medici Senza Frontiere, I governi raggiungano un accordo sulla sospensione dei brevetti durante la pandemia, 16 dicembre 2020
Human Rights Watch, Urgently Waive Intellectual Property Rules for Vaccine, Dec. 10 2020
A. Prabhala et al., Want Vaccines Fast? Suspend Intellectual Property Rights, The New York Times, Dec. 7 2020
Ann Danaiya Usher, South Africa and India push for COVID-19 patents ban Ann Danaiya Usher, The Lancet, Dec. 5 2020
C. Pellegrini, Emergenza sanitaria e brevetti sui vaccini, DirittoConsenso.it, 2 dicembre 2020
J.L. Contreras et al., Pledging Intellectual Property for COVID-19, 38 Nature Biotechnology 1146 (1 Dec. 2020) University of Utah College of Law Research Paper No. 405
Nicoletta Dentico, Silvio Garattini, Il nodo dei brevetti. I vaccini e i farmaci bene comune, 17 novembre 2020
A. Moerchel et al., Identifying Crisis-Critical Intellectual Property Challenges during the COVID-19 Pandemic: A Scenario Analysis and Conceptual Extrapolation of Innovation Ecosystem Dynamics Using a Visual Mapping Approach, 27 Oct. 2020
M. Dhenne, COVID-19: Hope for a New World of IP?, 19 Oct. 2020
WTO, The TRIPs Agreement and Covid-19, 15 Oct. 2020
A. Santos Rutschman, The Intellectual Property of COVID-19, Forthcoming, Outsmarting Pandemics, Elizabeth Kirley & Deborah Porter (Eds.) (2021), Saint Louis U. Legal Studies Research Paper No. 2020-28, 12 Oct. 2020
WTO, Waiver from Certain Provisions of the TRIPS Agreement for the Prevention, Containment and Tratment of COVID-19 – Communication from India and South Africa, IP/C/W/669, 2 Oct. 2020
India Gov., Agenda Item 15. Proposal for a waiver from certain provisions of the TRIPS Agreement for the prevention, containment and treatment of COVID-19, Document IP/C/W/669
F. Binda, R. Caso, Il diritto umano alla scienza aperta, in Trento LawTech Research Papers nr. 41, 27 settembre 2020
A. Tooze, The World Is Winning—and Losing—the Vaccine Race. Immunization to COVID-19 is supposed to solve our problems—but it’s starting to trigger even bigger ones, Foreign Policy, September 19, 2020
A. Santos Rutschman, The Intellectual Property of COVID-19, Forthcoming in Outsmarting Pandemics, Elizabeth Kirley & Deborah Porter (Eds.) (2021), September 11, 2020
J. Guimón, R. Narula, Ending the COVID-19 Pandemic Requires More International Collaboration, Research-Technology Management, 63:5, 38-41, September 8, 2020
E.G. Tse, D.M. Klug, M.H. Todd, Open science approaches to COVID-19 [version 1; peer review: 1 approved]. F1000Research 2020, 9:1043, August 25, 2020
P. Greco, La pericolosa corsa verso il vaccino, Il Bo live, 24 agosto 2020
J. de Beer, R.E. Gold, International Trade, Intellectual Property, and Innovation Policy: Long-Term Lessons from the COVID-19 Crisis (2020). C.M. Flood, V. MacDonnell, J. Philpott, S. Theriault & S. Venkapuram, eds, Vulnerable: The Policy, Law and Ethics of COVID-19 (Ottawa: University of Ottawa Press, 2020), 23 Aug 2020
Papa Francesco, Udienza generale, 19 agosto 2020
Open access journal posts COVID-19 preprint studies to reduce misinformation, New Medical Life Sciences, Aug 12 2020
E.K. Oke, Is the National Security Exception in the TRIPS Agreement a Realistic Option in Confronting COVID-19?, Aug 6 2020
M. Rimmer, Intellectual Property and Education in the Age of COVID-19, Aug 6, 2020
C.M. Ho, Avoiding the TRIPS Trap: A Path to Domestic Disclosure of Clinical Drug Data Consistent with International Norms, August 5, 2020
F.M. Abbott, The TRIPS Agreement Article 73 Security Exceptions and the COVID-19 Pandemic, Research Paper 116, South Centre, Geneva (August 2020), August 1, 2020
A. Capocci, I dati sulla pandemia non sono pubblici, Il Manifesto, 1 agosto 2020
WHO, WTO, Promoting Access to Medical Technologies and Innovation – Second Edition, July 29, 2020
G. Destro Bisol, Perché (e come) il coronavirus può aiutarci a raggiungere una “health information for all”, Il Bo, 29 luglio 2020
M. Capocasa, G. Destro Bisol, P. Anagnostou, Why (and how) COVID-19 could move us closer to the “health information for all” goal, 27 July, 2020
J. J. Lee, J.P. Haupt, Scientific globalism during a global crisis: research collaboration and open access publications on COVID-19, July 24, 2020
M. Wachowicz, Open Access to Scientific Innovation as a Means to Combat COVID-19, GRUR International, Volume 69, Issue 8, August 2020, Pages 783–784
A. Santos Rutschman, The COVID-19 Vaccine Race: Intellectual Property, Collaboration(s), Nationalism and Misinformation, Washington University Journal of Law and Policy, Vol. 64, 2020, July 21, 2020
M. Mucchetti, G. Zuanetti, Covid-19: fare Open science per dare risalto alla ricerca Italiana, AboutPharma online, 20 luglio 2020
R. Van Noorden, Open-access Plan S to allow publishing in any journal, Nature, 16 July 2020
Y. Heled, A.S. Rutschman, L. Vertinsky, The Need for the Tort Law Necessity Defense in Intellectual Property Law (July 3, 2020). University of Chicago Legal Forum, forthcoming. SSRN
UNESCO, COVID-19 – Open science and reinforced scientific cooperation
UNESCO, Open access to facilitate research and information on COVID-19
RDA COVID-19 Recommendations and Guidelines on Data Sharing, 30 June 2020
Y. Heled, A.S. Rutschman, L. Vertinsky, The Problem with Relying on Profit-Driven Models to Produce Pandemic Drugs (June 30, 2020). Journal of Law & Biosciences (2020, Forthcoming), Saint Louis U. Legal Studies Research Paper No. 2020-17. SSRN
Tham, Benjamin and Findlay, Mark James, COVID-19 Vaccine Research, Development, Regulation and Access (June 30, 2020). SMU Centre for AI & Data Governance Research Paper No. 2020/03, SSRN
J. D’Alessandro, Nobel, politici, personalità dello spettacolo. La lettera dei 101 per un vaccino anti Covid bene universale, Repubblica, 28 giugno 2020
J. Homolak, I. Kodvanj, D. Virag, Preliminary analysis of COVID-19 academic information patterns: a call for open science in the times of closed borders, 25 June 2020
J. Croft, Pandemic reopens wounds on IP rights. The ethics of pharmaceutical monopolies are under scrutiny, Financial Times, 18 June 2020
A. Barkan, Z. Rizvi, The Covid-19 Vaccine Should Belong to the People, The Nation, June 18, 2020
Patents, economics, and pandemics, 5 June 2020
Ewen Callaway, Will the pandemic permanently alter scientific publishing?, Nature, 3 June 2020, trad. it L’impatto della pandemia sulle pubblicazioni scientifiche, in Le Scienze, 11 giugno 2020
A. Uribe-Tirado, G. Del Río Riande, S. Raiher, J. Ochoa-Gutiérrez, Open Science since COVID-19: Open Access + Open Data. (June 3, 2020). Available at SSRN: or http://dx.doi.org/10.2139/ssrn.3621047
E. Hudson, P. Wragg, Proposals for Copyright Law and Education During the COVID-19 Pandemic (June 3, 2020)
Giovanna Borrelli, Francesco Sparano, La scienza dopo il nuovo coronavirus: aperta, cooperativa e solidale, Altraeconomia, 1 giugno, 2020
Publishers Sue Internet Archive Over Free E-Books, New York Times, 1 June 2020
Riccardo Petrella, Roberto Savio, Reinaldo Figueredo, I vaccini sono beni pubblici mondiali. La vita non è un brevetto, Il Manifesto, 30 maggio 2020
G. Blasi, La guerra sul Controlled Digital Lending negli USA. Le info di base per capirci qualcosa, Facebook, 30 maggio 2020
A. Capocci, Duecento scienziati contro la ricerca che ha fermato l’idrossiclorochina, Il Manifesto, 30 maggio 2020
Carlos Alvarado Quesada , Tedros Adhanom Ghebreyesus, Globalizing the Fight Against the Pandemic, Project Syndicate, May 29, 2020
An open letter to Mehra et al and The Lancet, May 28, 2020, Zenodo
S. Mancini, S. Egidi, Per favore, lasciamo perdere i brevetti per i vaccini, Repubblica, 27 maggio 2020
A. Dini, eBook gratis e cultura libera, dopo il sequestro torna raggiungibile il sito di Progetto Gutenberg, La Stampa, 26 maggio 2020
D. Rankovic, The Authors Guild demands National Emergency Library be shut down, Reclaim the Net, May 25 2020
Eve M.P., If I could radically reshape copyright law for research, May 23, 2020
E. Akpan, C. Ememobong, COVID-19 and the Rebirth of Compulsory Licensing: An Examination of the Right to Health Care (May 21, 2020). SSRN.
Brainard J., Will Trump White House tear down journal paywalls? Many anxiously await a decision, Science, 21 May 2020
A. Romano, COVID-19: la corsa al vaccino fra scienza, nazionalismi e solidarietà globale, Valigia blu, 21 maggio 2020
R. Kiley, Open access: how COVID-19 will change the way research findings are shared, 21 May, 2020
Coronavirus: everyone wins when patents are pooled, 20 May, 2020
C. Morten, A. Moss, Could a patent get in between you and a Covid-19 test? Yes, The Guardian, 20 May 2020
Jamali, D., Barkemeyer, R., Leigh, J. and Samara, G. (2020), Open Access, Open Science, and Coronavirus: Mega trends with historical proportions. Business Ethics: A Eur Rev. doi:10.1111/beer.12289
A. Capocci, Diritto al vaccino, c’è sempre la «crisi di sanità pubblica», Il Manifesto, 19 maggio 2020
L’appello di Msf: “Niente brevetti sui farmaci anti-Covid, devono essere disponibili per tutti”, Globalist, 18 maggio 2020
S. Boconetti, Il copyright che non piace ai colossi delle Multinazionali, Il Manifesto, 17 maggio 2020
S. Boseley, US and UK ‘lead push against global patent pool for Covid-19 drugs’, 17 May 2020
H. Wong, The case for compulsory licensing during COVID-19, J Glob Health. 2020 Jun; 10(1): 010358, 2020 May 15
E. Dusi, Vaccino, ecco perché non sarà per tutti. La Sanofi ha già promesso le prime dosi agli Usa, Repubblica, 14 maggio 2020
J. Grove, Coronavirus speeds journals’ shift towards open access, Times Higer Education, May 13, 2020
OECD Policy Responses to Coronavirus (COVID-19), Why open science is critical to combatting COVID-19, 12 May 2020
R. Mazzaracca, Brevetti e proprietà intellettuale al tempo del Coronavirus, Osservatorio Terapie Avanzate, 11 maggio 2020
J.E. Stiglitz, Il mercato dei farmaci deve cambiare, Internazionale, 10 maggio 2020
All that’s fit to preprint. Nat Biotechnol38, 507 (2020). https://doi.org/10.1038/s41587-020-0536-x
E. Cristofori Rapisardi, Vaccini e brevetti, il dilemma della proprietà intellettuale, Il Sole 24 ore, 5 maggio 2020
V. Zambrano, Il «diritto umano alla scienza» e l’emergenza da CoViD-19, in Rivista di biodiritto/Biolaw Journal, maggio 2020, http://dx.doi.org/10.15168/2284-4503-584
J. Shopovski, B. Sloboda, COVID-19 Pandemic, the Value of Open Access to Research, and Role of Agile Peer Review (May 3, 2020). European Scientific Journal, ESJ (2020)
D. Kansra, COVID-19: Time to Invest in the Human Right to Science, May 1, 2020
V. Porcheddu, La cura del reperto al tempo del virus, Il Manifesto, 28 aprile 2020
Mariana Mazucato, Else Torrele, Come sviluppare un vaccino anti-COVID-19 per tutti, Project Syndicate, Apr 27, 2020
M. Santolini, Covid-19: the rise of a global collective intelligence?, The Conversation, April 24, 2020
Joseph E. Stiglitz , Arjun Jayadev, Achal Prabhala, Patents vs. the Pandemic, Project Syndicate, Apr 23, 2020
A. Di Corinto, “Io leggo digitale”, l’iniziativa italiana (e non solo) per leggere da casa gratis, Repubblica, 17 aprile 2020
S. Bocconetti, Usa, i signori del copyright contro i libri gratuiti per gli studenti poveri, Il Manifesto, 15 aprile 2020
M. Sagone, Proprietà intellettuale e emergenza sanitaria, Studio Torta, 10 aprile 2020
Coronavirus, Gallo (M5S): subito legge Open science e sostegno alla ricerca, 8 aprile 2020, Orizzontescuola.it
The Open COVID Pledge, Apr 7, 2020
UN Committee on Economic, Social and Cultural Rights (CESCR), Committee adopts statement on the Covid-19 Pandemic and Economic, Social and Cultural Rights, 6 April 2020
Le valvole per i respiratori prodotte con una stampante 3D, Sena e Tarchini, 5 aprile 2020
Scienza aperta e valutazione della ricerca in tempi di crisi pandemica: lettera aperta dell’AISA al Presidente della Repubblica, 30.03.2020
WIPO, COVID-19 IP Policy Tracker
M. Sandal, Come la pandemia sta cambiando il mondo della ricerca scientifica, in Il Tascabile, 27.3.2020
Roberto Caso, La scienza non sarà più la stessa. Più condivisione, cooperazione e solidarietà dopo il Covid-19?, 25 marzo 2020
V. Neetha K., Aaron Swartz: As JSTOR opens it doors amid pandemic, people laud hacker who fought for access to knowledge, Mar. 22, 2020
Yamey, Gavin and Schäferhoff, Marco and Pate, Muhammad and Chawla, Mukesh and Ranson, Kent and Hatchett, Richard and Wilder, Richard, Funding the Development and Manufacturing of COVID-19 Vaccines. Background paper for the World Bank/CEPI financing COVID-19 vaccine development consultation on February 20, 2020. The Center for Policy Impact in Global Health., Duke Global Working Paper Series No. 20, March 2020.SSRN
Vincent W.J. van Gerven Oei, Viral Open Access in Times of a Global Pandemic, Mar. 19, 2020
M. Sandal, Il coronavirus sta cambiando il modo in cui pensiamo alla scienza, in Esquire, 10.03.2020
K. Kupferschmidt, ‘A completely new culture of doing research.’ Coronavirus outbreak changes how scientists communicate, in Science, Feb. 26, 2020
X. Xu, The hunt for a coronavirus cure is showing how science can change for the better, in The Conversation, Feb. 24, 2020
Bo XuMoritz, U. G. Kraemer on behalf of the Open COVID-19 Data Curation Group, Open access epidemiological data from the COVID-19 outbreak, The Lancet – Infectious Diseas, February 19, 2020, DOI:https://doi.org/10.1016/S1473-3099(20)30119-5
V. Larivière, F. Shuet, C.R. Sugimoto, Coronavirus et édition savante : une question de transmission, in Acfas Magazine, 13 février 2020,
Calling all coronavirus researchers: keep sharing, stay open, in Nature, 578 (7) 2020
F. Binda e A. Boggio, Scienza aperta per combattere il coronavirus, 21.02.2020
R. Pells, Coronavirus and Ebola: could open access medical research find a cure?, in The Guardian, Jan. 22, 2020
EPO-European Patent Academy, Compulsory licensing in Europe -A country-by-country overview, 2018
